Peptide cancer research in the UK: what CLARITY will test
Understand the UK CLARITY peptide cancer trial: what CY-101 is being studied for, why the trial matters and what has not yet been established.
Trial news: 14 July 2026THE INSTITUTE UK EDITION / 01
Research moves forward.
Understanding should too.
Positive developments in UK peptide science, read with perspective. Original research briefings and practical guides to the evidence behind the label.
06 articlesUK sources & contextPublished 25 October 2026
The work worth following.
RECENT UK RESEARCHPeptide innovation at Kent: a new route for protein production
Explore Kent’s 2026 vesicle-nucleating peptide study and what a better protein-production platform could mean for UK laboratory research.
Research: August 2026 journal issuePeptide research at Leeds: why membrane selectivity matters
Read a UK-focused explanation of Leeds’ September 2026 MP-1 peptide study, including membrane selectivity, laboratory models and evidence limits.
Study published online: 24 September 2026A clearer way to assess the evidence.
FOR UK LABORATORIESHow to read a peptide COA: a checklist for UK laboratories
Check a peptide certificate of analysis with a UK-focused guide to lot numbers, identity, purity methods, laboratory scope and missing evidence.
Practical guide · UK laboratoriesResearch peptide storage: a UK laboratory guide to the right questions
Compare lyophilised and in-solution research peptide storage using product-specific UK examples, receipt checks and a practical cold-chain record.
Practical guide · UK laboratoriesBuying research peptides in the UK: an evidence-first checklist
A UK laboratory procurement checklist covering supplier identity, batch reports, formulation, dispatch location, storage evidence and research-use claims.
Practical guide · UK laboratoriesSources first.
Claims kept in context.
The Institute is the editorial library of Selective Peptides. We cover UK research and laboratory procurement questions using linked source material. Publication dates and evidence levels are shown so that a clinical trial, a laboratory result and a supplier statement remain distinct.
News coverage draws on research institutions and study records. The guides set out our own document-review questions. We have no affiliation with the universities or trials covered, and no external clinical review is claimed.
Our catalogue and supplier documents remain subject to review. Research coverage does not endorse a product or provide treatment, dosing or administration advice.
Inspect the source report tree ↗